Resumen
Background: Preliminary studies have suggested that the renin-angiotensin system is activated in critical illness and associated with mortality and kidney outcomes. We sought to assess in a larger, multicenter study the relationship between serum renin and Major Adverse Kidney Events (MAKE) in intensive care unit (ICU) patients. Methods: Prospective, multicenter study at two institutions of patients with and without acute kidney injury (AKI). Blood samples were collected for renin measurement a median of 2 days into the index ICU admission and 5–7 days later. The primary outcome was MAKE at hospital discharge, a composite of mortality, kidney replacement therapy, or reduced estimated glomerular filtration rate to ≤ 75% of baseline. Results: Patients in the highest renin tertile were more severely ill overall, including more AKI, vasopressor-dependence, and severity of illness. MAKE were significantly greater in the highest renin tertile compared to the first and second tertiles. In multivariable logistic regression, this initial measurement of renin remained significantly associated with both MAKE as well as the individual component of mortality. The association of renin with MAKE in survivors was not statistically significant. Renin measurements at the second time point were also higher in patients with MAKE. The trajectory of the renin measurements between time 1 and 2 was distinct when comparing death versus survival, but not when comparing MAKE versus those without. Conclusions: In a broad cohort of critically ill patients, serum renin measured early in the ICU admission is associated with MAKE at discharge, particularly mortality.
| Idioma original | English |
|---|---|
| Número de artículo | 294 |
| Publicación | Critical Care |
| Volumen | 25 |
| N.º | 1 |
| DOI | |
| Estado | Published - dic 2021 |
Nota bibliográfica
Publisher Copyright:© 2021, The Author(s).
Financiación
AHF is supported by a pre-doctoral fellowship from KidneyCure/American Society of Nephrology. PD is supported by grants from NIDDK (P50DK096418) and NHLBI (R01HL133695). OWM is supported by NIDDK (R01DK081423, R01 DK115703, R01 DK091392), the O’Brien Kidney Research Center (P30 DK-079328), and the Charles Pak Foundation. JAN is currently supported by grants from NIDDK (R56 DK126930 and P30 DK079337) and NHLBI (R01 HL148448-01 and R21 HL145424-01A1). AHF is supported by a pre-doctoral fellowship from KidneyCure/American Society of Nephrology. PD is supported by grants from NIDDK (P50DK096418) and NHLBI (R01HL133695). OWM is supported by NIDDK (R01DK081423, R01 DK115703, R01 DK091392), the O?Brien Kidney Research Center (P30 DK-079328), and the Charles Pak Foundation. JAN is currently supported by grants from NIDDK (R56 DK126930 and P30 DK079337) and NHLBI (R01 HL148448-01 and R21 HL145424-01A1). AHF and PD have received grant funding from La Jolla Pharmaceutical company. The remaining authors have disclosed that they do not have any competing interests. This study was supported in part by the University of Texas Southwestern Medical Center O’Brien Kidney Research Core Center (NIH, P30 DK079328-06); the University of Kentucky Center for Clinical and Translational Science (NIH/NCATS, UL1TR001998).
| Financiadores | Número del financiador |
|---|---|
| KidneyCure/American Society of Nephrology | |
| O?Brien Kidney Research Center | |
| George O’Brien Kidney Research Center | P30 DK-079328 |
| University of Texas Southwestern Medical Center O’Brien Kidney Research Core Center | |
| National Institutes of Health (NIH) | |
| National Heart, Lung, and Blood Institute (NHLBI) | R01DK081423, R01 DK091392, R01 DK115703, R01HL133695 |
| National Institute of Diabetes and Digestive and Kidney Diseases | P30DK079328, P50DK096418 |
| La Jolla Pharmaceutical Company | |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998 |
| Charles Pankow Foundation | R56 DK126930, R21 HL145424-01A1, R01 HL148448-01, P30 DK079337 |
| University of Kentucky, Center for Clinical and Translational Science |
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine